Advertisement

Abbott Launches World's First Glucose Monitor for Athletes

Abbott Launches World's First Glucose Monitor for Athletes

Glucose biosensors are typically used by people with diabetes to track their blood sugar levels while avoiding traditional finger-stick tests that accomplish the same goal. Abbott Laboratories (NYSE: ABT) has decided to adapt the technology used in its FreeStyle Libre diabetes system to help athletes monitor their glucose levels with a new device called the Libre Sense Glucose Sport Biosensor. The biosensor, which will launch soon in eight European countries, is worn on the back of the athlete's upper arm and gives real-time glucose data available through mobile phone apps and wrist readers.